CDEK
← All organizations

Merus Labs

For profit

Also known as: Merus NV | Merus N.V. | MERUS N.V.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2015

First marketed drug

Dec 4, 2024

Last known activity

Sep 25, 2024

Acquired by Genmab on Oct 1, 2025

Timeline

2010s

  1. Jan 1, 2011

    Merus Labs— Founded

2020s

  1. Dec 4, 2024

    zenocutuzumab— Marketing Organization

  2. Oct 1, 2025

    Genmab— Acquired By

Drugs by trial phase (11 distinct, 10 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (13)

Details

Founded
Vancouver, CA Jan 1, 2011
Last known activity
Sep 25, 2024